Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Wednesday, July 6, 2022.
Arcutis Biotherapeutics, Inc. - Common stock (NASDAQ:ARQT)
Countertrend Up (+85) - ARQT is showing short-term weakness. However, look for the longer-term bullish trend to resume. As always, continue to monitor the trend score and utilize a stop order.
Is it time to buy, sell, or avoid ARQT?
MarketClub looks at technical strength and momentum to determine if the timing is right for ARQT.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for ARQT
The long-term trend has been UP since May 24th, 2022 at 22.17
The intermediate-term trend has been UP since May 24th, 2022 at 22.12
The short-term trend has been DOWN since Jun 24th, 2022 at 20.61
Smart Scan Analysis for ARQT
Based on our trend formula, ARQT is rated as a +85 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 21.55 | 22.13 | 21.40 | 21.98 | +0.25 |
| Prev. Close | Volume | Bid | Ask | Time |
| 21.96 | 353909 | 2022-07-05 15:59:40 |
| 52wk High | 27.45 | 52wk High Date | 2021-07-13 |
| 52wk Low | 13.59 | 52wk Low Date | 2022-01-28 |
| Average Volume | 495,672 | Shares Outstanding | 51,418 |
| Assets | 364,109,000M | Liabilities | 110,337,000M |
| P/E Ratio | -6.43880000 |